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Glycosaminoglycans (GAGs) are unbranched, polysaccha-
ride chains which, with the exception of hyaluronan (HA),
are highly sulphated and constitute the glucidic moieties
of proteoglycans (PGs) macromolecules. Depending on
monosaccharide composition and protein linkage region, as
well as sulphation pattern and degree, GAGs can be grouped
in four subfamilies named chondroitin/dermatan sulphate
(CS/DS), heparan sulphate/heparin (HS/HE), hyaluronan
(HA), and keratan sulphate (KS).
GAGs contribute to the PGs native folding and functions,
as well as to tissue and organ behavior. In fact, GAGs are
involved in stabilization of the fibrillar extracellular matrix
(ECM), control of hydration, regulation of tissue, and organ-
ism development by controlling cell cycle, cell behavior, and
diﬀerentiation. HA synthesis is a process carried out on
plasma membrane by specific enzymes called Hyaluronan
synthases. The other GAGs chains are polymerized in the ER
and Golgi compartments by specific enzymes drawn close in
a complex named GAGosome. The modification of the syn-
thesis of the GAG portion of PGs orHA can alter significantly
the ECM structure and composition, with multiple eﬀects,
leading to physiological events such as tissue ageing and
pregnancy or pathological events: kidney agenesis, cardiac
malformations, abnormal mast cells, somatic overgrowth,
lung dysfunction, chondrodysplasia, tumor progression, and
fibrosis process.
On the other hand, the same studies about GAGs
involvement in cell diﬀerentiation have led in the last decade
to the use of GAG chains in the preparation of innovative
and biocompatible materials. GAGs are incorporated into
polymer scaﬀolds for tissue regeneration in order to improve
their physiochemical properties, such as water-binding abil-
ity, and to influence cell behavior. Certain biomaterials
contain GAGs as their main component. For example, in
biomaterials aimed to blood contact, heparin is applied to
counteract blood clotting. Furthermore, growth factors are
often applied together with scaﬀolds and GAGs, due to the
well known ability of various GAGs to bind specific growth
factors and to modulate their activity and bioavailability.
In this special issue on GAGs, we have invited papers that
address such issues, both by original work and reviews.
One of the papers of this special issue shows that CS/DS
GAGs and HA are diﬀerently distributed between peri-
cardium and valves and within heart valves themselves before
and after decellularization. Distribution of glycosamino-
glycans is also dependent from the vascular district and
topographic localization. Data presented suggest that both
decellularized porcine heart valves and bovine pericardium
represent a promising material for future development of
tissue engineered heart valve scaﬀolds.
The paper by E. Zinellu et al. compares the amount and
sulphation characteristic of CS present in plasma of patients
with hard and soft carotid arteriosclerotic plaques to the one
found in plasma of healthy volunteers. The authors suggest
that the diﬀerences evidenced in the paper could be used to
develop new diagnostic tests for atherosclerosis.
The authors of the paper entitled “Glycosaminoglycan
storage disorders: a review” reviewed the clinical conse-
quences of alteration in degradation of GAGs. Intralysosomal
accumulation of undegraded products causes a group of
lysosomal storage disorders known as mucopolysacchari-
doses (MPSs). They provide an overview of the molecular
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basis, enzymatic defects, clinical manifestations and diag-
nosis of each MPSs, focusing also on the available animal
models and describing potential perspectives of therapy for
each one.
Other authors documented the eﬀects on diabetic
nephropathy of the treatment with low-molecular-weight
heparin (dalteparin, LMW-HE). Patients with type 2 diabetes
and with neuro-ischemic foot ulcers were given LMW-HE
for a maximum of six months. The authors showed that
LMW-HE is beneficial for the outcome of neuro-ischemic
foot ulcers and it has no eﬀect on glomerular function despite
an increment of excretion of GAGs. Moreover they stated
that urinary IgM and IgG (consequence of alterations of
the size-selective properties of the glomerular capillary wall)
seem to be better markers than albuminuria for detecting
and predicting renal injury in the patients. Evidences from
this paper contribute to highlight the complex role of the
GAG heparin, which can influence directly and indirectly
the structure and the function of the glomerular capillary
wall and therefore plays a pivotal role in diabetes and kidney
diseases.
One of the papers investigates more on the same topic,
that is, the importance of GAGs distribution on the endothe-
lial surface, by focusing on a diﬀerent pathology. Starting
from defining the problem of acute coronary syndrome,
the authors described the importance of a good reperfusion
therapy on the recovery of a proper microcirculation in
damaged heart tissue. An adequate capillary circulation is
a necessary prerequisite for normal perfusion and organ
functioning, and a no-reflow phenomenon is defined as
incomplete reperfusion at the microcirculatory level. Under
this perspective, the composition of the endothelial glycoca-
lyx in terms of GAGs, PGs, and glycoproteins is significant
in defining its role as protective layer of the vascular wall.
The no-reflow phenomenon is therefore strictly related to
the composition of the glycocalyx, and the authors discuss
how the deep knowledge of this layer (drug targeting,
ultrastructure, and degradation) could be helpful in the best
reperfusion outcome.
Another paper reviews the occurrences, the synthesis,
and the catabolism of hyaluronan, followed by a description
of HA receptors and the relevance of the chain length in
aﬀecting diﬀerent aspects of cell and tissue behavior. The
authors also mention the role of hyaluronan in malignancy
and skin, discussing its new recently discovered functions.
In the same field, the paper by M. A. Solis et al. of
the issue combines the review of hyaluronan properties and
biological activities (strictly dependent on its dimension and
receptors) with the research for a perfect microenvironment
in which stem cells can be grown and/or diﬀerentiated. HA
has a pivotal role in development and diﬀerentiation of cells,
tissue, and organism, and stem cells present most of the HA
receptor on their membrane, indicating the perfect match for
their appropriate niche biomaterial.
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